Recent Posts

Showing posts with label fill in blanks. Show all posts
Showing posts with label fill in blanks. Show all posts

Thursday, 5 July 2018

// // Leave a Comment

PK Gupta Series 13: Toxicology MCQ and Fill in the Blanks


PK Gupta Series 13: Toxicology  MCQ and Fill in the Blanks

Exercise 

Q. 1. All of the following are hydrolytic enzymes except---------
a) carboxylesterase
b) alcohol dehydrogenase
c) cholinesterase
d) paraoxonase
Q. 2. All of the following are true of epoxide hydrolyases except------------
a) they add oxygen to a double bond and form a 3-member ring
b) they are important in hydrolyzing electrophiles
c) they play a role in converting benzo(a)pyrene to a carcinogen
d) some forms are inducible
Q. 3. Nitroreductase plays an important role in ----------
a) nasal epithelium
b) lung Clara cells
c) white blood cells
d) intestinal flora
Q. 2. A drug that undergoes sulfoxide reduction is --
a) haloperidol
b) chloramphenicol
c) thaliomide
d) sulindac
Q. 5. Quinidine oxidoreductases are thought to play a protective role in -------
a) liver toxicity of microcystin
b) bone marrow toxicity of benzene
c) renal toxicity of aminoglycosides
d) neurotoxicity of n-hexane
Q. 6. All of the following are mechanisms for removing halogen atoms aliphatic xenobiotics except ---------------------
a) Grignard dehalogenation
b)reductive dehalogenation
c)oxidative dehalogenation
d)double dehalogenation
Q. 7. Oxidation of ethanol to acetaldehyde takes place in-
a) cytosol
b) microsomes
c) peroxisomes
d) all of the above
Q. 8. Reductive dehalogenation of carbon tetrachloride produces -------
a) phosgene
b) chloroform
c) trichloromethyl radical
d) hydrochloric acid
Q. 9. Acetaldehyde is converted to acetic acie by ALDH2 in ---------------
a) mitichondria
b) cytosol
c) microsomes
d)all of the above
Q. 10. Aldehyde oxidase and xanthene oxidoreductase contain -----------
a) zinc
b) molebdenum
c) selenium
d) copper
Answers
1.       b; 2. a; 3. d; 2. d; 5. b; 6.a ; 7.d; 8. c; 9. a; 10. b .

Exercise

Q. 1. Slow acetylators of NAT demonstrate all of the following except--------
a) peripheral neuropathy from isoniazid
b) systemic lupus erythematous from procainamide
c) peripheral neuropathy from dapsone
d) decreased hypotensive response from hydrazine
Q. 2. In contrast to glucuronidation, sulfonation is ----
a) a low-affinity, low-capacity pathway
b) a low-affinity, high-capacity pathway
c) a high-affinity, high-capacity pathway
d) a high-affinity, low-capacity pathway
Q. 3. Induction of sulfotransference enzymes by rifampin be clinically relevant for -----------
a) warfarin
b) digoxin
c) ethinyl estradiol
d) all of the above
Q. 2. All of the following statements regarding sulfonation reaction are true except -------
a) they can take a molecule less lipid soluble
b) they always detoxify a molecule
c) some drugs must be metabolized to a sulfonate conjugate to have pharmacologic effect
d) morphine-6-sulfate is more potent than morphine in the rat
Q. 5. All of the following statements are true regarding methylation except-------------
a) the process generally decreases the water solubility of the parent
b) the process can mask functional groups that can be metabolized by other conjugation enzymes
c) inorganic mercury and arsenic can be dimethylated
d) high methyltransferace activity may lower levels of homocysteine
Q. 6. All of the following are methyltransferase enzymes except --------------
a) SAM
b) COMT
c)NNMT
d) HNMT
Q. 7. All of the following are true of glucuronide conjugates of xenobiotics except ---------------
a) they can excreted in the urine
b)thaey are formed from activated xenobiotics
c) they are substances for beta-glucuronidase in the intestinal flora
d) they can excreted into bile
Q. 8. All of the following are true of sulfonation reaction except -----------
a) they involve the transfer of sulfate
b) they are catalyzed by sulfotransferaces
c) the cofactor of the reaction is PAPS
d) they are mainly excreted in the urine
Q. 9. The number of UGT mammalian enzymes that have been identified is approximately ---
a) 5
b)12
c)22
d) 58
Q. 10. In addition to cytoplasm, sulfotranferaces are present in mammals in the -------------
a) endoplasmic reticulum
b) mitochondria
c) plasma membrane
d)Golgi apparatus
Answers
1.       d; 2. d; 3. c; 2. b; 5.d ; 6. a; 7, b; 8. a; 9.c; 10.  d.

Fill in the blanks

Exercise

Q. 1. The most common process of absorption of xenobiotics across the cell membrane is -------------------.
Q. 2. The important route of excretion for xenobiotics is ---------------------.
Q. 3. The process of chemical transformation (conversion from one form to another) occurring in the body is known as----------------------------.
Q. 2. The major site for biotransformation of xenobiotics in body is---------------.
Q. 5. In a hepatocyte, metabolism of xenobiotics takes place in-----------------------------------------------------------------------------.                              .
Q. 6. The most important among microsomal enzymes is --------------------or------------------------------------------.
Q. 7. The major biotransformation reaction occurring in Phase I is ------------------and in Phase II is -------------------.
Q. 8. Phase I Oxidation reactions are mainly catalyzed by -----------------------------------------.
Q. 9. All Phase II conjugation reactions are catalysed by non- microsomal enzymes except for ------------------------------------ which is catalysed by microsomal enzymes.
Q. 10. The ability of certain substances to increase the activity or synthesis of microsomal enzymes is known as ------------------------------.
Q. 11. The metabolic reaction, which is deficient in dogs is---------------------; Cats are deficient in ---------------------------------------and Pigs are deficient in ------------------- reactions of biotransformation.
Q. 12. The process of conversion of nontoxic substance into a toxic metabolite due to biotransformation is known as --------------------------------.
Answers
1. Passive diffusion; 2. RENAL EXCRETION; 3. BIOTRANSFORMATION; 2. LIVER(Liver is the major site due to the presence of variety of metabolizing enzymes. Other important sites for biotransformation include lung, kidney and intestines); 5. ENDOPLASMIC RETICULUMN (ER) or MICROSOMES.; 6. MONOOXYGENASES or MIXED FUNCTION OXIDASES (MFO); 7. OXIDATION and  CONJUGATION; 8. MICROSOMAL ENZYMES (MFO); 9. GLUCURONIDE  CONJUGATION; 10. INDUCTION (Non-microsomal enzymes which are present in cytosol are not inducible) –microsomal enzymes which are present in cytosol are not inducible); 11. ACETYLATION; GLUCURONIDE CONJUGATION and SULFATION; (Hence, sulphonamides which undergo acetylation cause toxicity in dogs and similarly, paracetamol, which undergoes glucuronide conjugation, causes hepatotoxicity in cats). 12. LETHAL SYNTHESIS.

True and False Statements

Exercise 

True and False statement. Write T for true and F for false statement.

Q.1. A water-soluble drug will pass across muscle membranes faster than across brain membranes (assume permeability-rate limitations).
Q.2.A neutral, lipophilic drug is likely to be absorbed faster in the intestines than in the stomach. Remember that stomach and intestine differ in their properties.
Q.3.Lipophilic drugs are generally taken up fast by highly perfused organs.
Q.2.Ionized and lipophilic drugs are most likely to cross most membrane barriers.
Q.5.Drugs with a high tissue binding always have a large volume of distribution.
Q.6.Compared to skin, liver would have a higher rate of uptake of perfusion-limited lipophilic drugs due to its higher blood flow rate.
Q.7.Distribution to a specific tissue for permeability-limited hydrophilic drugs depends on how much and how quickly the blood gets to the specific tissue.
Q.8.Perfusion limited distribution is a type of drug distribution into tissue that occurs when the drug is able to cross membranes easily.
Q.9. Assume two drugs (identical molecular weight, same dose given): one neutral drug (Drug A) and one acidic drug (pka=7.4, Drug B). Drug A and the unionized form of drug B have the same partition coefficient. The fraction unbound in plasma and tissue is 0.5 for both drugs. Drug B will enter tissues somewhat slower than drug A.
Q.10. A weak acid, whose unionized form shows a high partition coefficient is likely to cross most membrane barriers.
Answers
1.T; 2.T; 3.T; 2.F; 5. F; 6.T; 7. F; 8. T;  9.T;10.T

Read More

Wednesday, 21 March 2018

// // 1 comment

PK Gupta Series 7: Multiple Choice Questions and fill in blanks TOXICOLOGY Question and Answer bank.


Series 7: Multiple Choice Questions and fill in blanks

Multiple Choice Questions

Exercises
Q. 1. Examples of significant concentrations of a toxicant in a tissue that is not a target organ include all of the following except-----------.
a) lead in bone
b) DDT in adipose tissue
c) paraquat in lung
d) TCDD in adipose tissue
Q. 2. the ability of a chemical to cause acute skin and eye irritation is usually evaluated in a ------
a) rabbit
b) rat
c) mouse
d) dog
Q. 3.  before a potential pharmaceutical compound can be given to humans .-------.
a) an NDA must be filed with the FDA
b) an IND must be filled with the FDA
c) acute toxicity studies on 4 species must be conducted
d) a 2-year dog carcinogenicity study must be completed
Q. 4.  phase 1 clinical trials are conducted to determine all of the following except ---
a) pharmacokinetics
b) safety
c) rare adverse effects
d) preliminary efficacy
Q. 5. MTD stands for ------------------
a) minimum tolerated dose
b)maximum total dose
c) maximum tolerated dose
d) maximum threshold dose
Q. 6. the acute toxicity study in animals provides ------
a) an appropriate lethal dose
b) information on target organs
c) information on dose selection for long-term studies
d)all of the above
Q. 7. a subacute toxicity study in rats usually lasts ------.
a) 3 days
b)14 days
c) 3 months
d) 6 months
Q. 8. the period of organogenesis in rats is ---.
a) day 3-10
b) day 7-17
c)  day 12-25
d) day 17-56
Q. 9.  a dose of investigational drug that suppresses body weight gain slightly in a 90-day animal study is defined by some regulatory agencies to be-------.
a) LOAEL
b) NOAEL
c)MTD
d) reference dose
Q. 10. a subchronic animal study required by the FDA will usually include-----
a) two species (usually one rodent and one nonrodents)
b) both genders
c) at least three doses (low, intermediate, and high)
d) all of the above

Q.11 A dose of a compound A is toxic to animals in vivo. Another chemical B is not toxic when given at doses several orders of magnitude higher but when the two are given together the toxic response is greater than that of the given dose of A alone.
a) antagonism
b) synergism
c) additivity
d) potentiation
e) none of the above
Q.12 Which information may be gained from an acute toxicity study
a) no effect level
b) LD50 
c) therapeutic index
d) target organ
e) all of the above
Q.13The therapeutic index is usually defined as
a) TD50 / LD50 
b) ED50 / LD50 
c) LD50   / ED50
d) ED50  / TD50
e) LD50   / ED50
Q.14 1000 ppm is equivalent to 1%
a) True
b) False

Answers
1. c;      2. a;      3. b ;     4.c ;      5.c ;      6.d ;      7.b ;     8.b ;      9.c ;      10. d; 11. d; 12. e; 13. c ; 14. b.

Fill in blanks

Q. 1. The branch of science which deals with the harmful effects of physical and chemical agents of human and animal life is ------------------------------------
Q. 2. In the term toxicology, the word ‘toxicon’ (Greek) means --------------------
Q. 3. The branch of toxicology, which deals with diagnosis, treatment and management of toxic substances, is known as -----------------------------------
Q. 4. The development and interpretation of mandatory toxicology testing programs is addressed by -------------------------------------------
Q. 5 Investigating and controlling the toxic effects of various substances on the community is dealt by ----------------------.
Q. 6. The study of toxicity produced by subsances of plant, animal and microbial origin is termed as -------------
Q. 7. A foreign chemical substance, which is not normally produced in the body or forms a part of the food, is known as --------------------.
Q. 8. The source of adverse effect/ damage is known as ----------------------
Q. 9. The likelyhood/probability of adverse effect upon exposure to a hazard is known as --------------------.
Q. 10. The statement, “all substances are poisons; the dose differentiates poison from a remedy” is associate with -------------------------.

Answers
1.TOXICOLOGY; 2. POISON; 3.CLINICA L TOXICOLOGY; 4. REGULATORY TOX COLOGY; 5 TOXICOVIGILANCE; 6. TOXINOLOGY; 7. XENOIOTIC; 8 HAZARD. (eg: Water containing Fluoride; Here fluoride is the hazard and fluorosis is the adverse effect. Hazard is independent of dose or exposure i.e., it is present whether someone drinks the water or not).
9. RISK. (eg: While drinking water containing fluoride, the chances of getting fluorosis is called risk. Risk can range from 0 to 100% depending on dose and exposure i.e., one should be exposed to a hazard to calculate the risk); 10. PARACELSUS

Exercises
Q. 1 The scientist referred to as ‘Father of Toxicology’ is ------------------------
Q. 2.  DDT (Dichlorodiphenytrichloro ethane) which is used to control malaria and typus was discovered by ----------------------------
Q. 3. The person who is known as ‘Father of Nerve Agents’ is ------------------------------
Q. 4. The author of the book ‘Silent Spring’ in which the detrimental effect of DDT and other pesticides on environment –particularly on birds was document is -------------------------. 
Q. 5. Bhopal gas tragedy, which is considered to be the world’s worst industrial disaster, was caused due to the leakage of------------------------------------ from Union Carbide fertilizer company.
Q. 6. Use of thalidomide in pregnant women for treating women for treating morning sickness led to -------------------------condition in the infants.
Q. 7. If the action of one substance opposes or neutralizes the effect of another substance, the relationship is referred to as -------------------------..
Q. 8. Rodents are preferred for oral toxicity testing as they lack ------------------ reflex.
Q. 9. Maximum acceptable/ permitted amount of a drug present in feed and foods is known as ----------------------------------------------------------------------.
Q. 10. The highest dose of a compound, which produces adverse effects but no mortality is called -----------------------------------------------------------------------.
Answers
1. M.J.B. Orfila; 2. Pau Muller; 3 GERHARD SCHRADER; 4. RACHEL CARSON;5. METHYL-ISOCYANATE (MIC); 6. PHOCOMELIA; ;7. ANTAGONISM (All antidotes have antagonistic relationship with their respective toxicants) have antagonistic relationship with the irrespective toxicants); 8. VOMITION; 9 MAXIMUM RESIDUE LEVEL (MRL). (For pesticides – MAXIMUM RESIDUE LIMIT); 10 MAXIMUM TOLERATED DOSE {(MTD),  MTD is also referred to as LD0 (Zero) as it will cause adverse effects but no mortality)}.

Exercise
Q.1. If the period of exposure of a toxicant is more than 3 months, the type of study is termed as ---------------------.
Q. 2. The type of toxicity which results due to progressive accumulation of a toxicant in the body is known as ------------------------------.
Q. 3. The amount of toxicant in food and water, which can be consumed daily over a life time without any significant health risk, is called as ------------------------------------------.
Q. 4 Unlawful or criminal killing of animals through administration of poisonsis known as -----------------------
Q. 5. Unintentional addition of toxicants and contaminants in feed  and water is known as ----------------------.
Q. 6. Man -made sources of toxicants are referred to as ------------------------ sources.
Q. 7. Genetically determined abnormal reactivity of an individual to a chemical is known as----------------------------..
Q. 8. Failure to elicit a response to an ordinary dose of a substance due prior usage is known as --------------------------.
Q. 9. The beneficial effects of toxic substances at low doses are known as-----------------.
Q. 10. In the event of irreparable injury, the cell undergoes a process of programmed cell death known as ----------------------------.
Q. 11 A substance is classified as extremely toxic if the lethal dose (LD) is LESS THAN ------------- and as practically non-toxic if the LD is ------------.
Q. 12. The ability of a substance to induce cancer is known as ------------------.    

Answers
1. CHRONIC TOXICITY; 2. CUMULATIVE TOXICITY(Several toxicants such as heavy metals, alcohol, DDT etc cause cumulative toxicity.); 3. ACCEPTABLE DAILY INTAKE (ADI); 4. MALICIOUS POISONING; 5. ACCIDENTAL POISONING; 6. ANTHROPOGENIC; 7. IDIOCYNCARY; 8. TOLERANCE(Tolerance is generally caused due to the induction of metabolizing enzymes in liver. However, in case of chronic alcoholism, pseudo-tolerance is observed, due to thickened GIT mucosa, which reduces absorption);

9. HORMESIS; 10. APOPTOSIS(Apoptosis is also involved in number of physiological process such as embryogenesis, ageing, cancer prevention etc); 11. 1mg/kg, 5 to 15 g/kg(It should be remembered that more the LD of a compound, less is its toxicity); 12. CARCINOGENESIS

FURTHER READING

Gupta PK (2018) Illustrative Toxicology with Question bank. 1st Edition. Elsevier, USA

Gupta PK (2016) Fundamentals of Toxicology: Essential concepts and applications. 1st Edition. ISBN-9780128054260, pp 438, BSP/Elsevier, USA

The Merck Veterinary Manual (2016). Chapter “Herbicide Poisoning” by PK GUPTA 11th edition, Merck & Co. Inc Whitehouse Station, NJ, USA  2969-99

The Merck Veterinary Manual (2016). Chapter “Pentachlorophenol Poisoning” by PK GUPTA 11th edition, Merck & Co. Inc Whitehouse Station, NJ, USA  pp 3052-53

Gupta PK (2016) Essential Concepts in Toxicology. Published by PharmaMed Press (A unit of BSP Books Pvt. Ltd), Hyderabad, India pp 362.

Gupta PK (2010) Modern Toxicology, Basis of organ and reproduction toxicity. Vol 1. Published by Pharma  Med Press (A unit of BSP Books Pvt. Ltd). Hyderabad, India pp 1-460.

Gupta PK (2010) Modern Toxicology, Adverse effects of xenobiotics. Vol 2, Published by PharmaMed Press (A unit of BSP Books Pvt. Ltd). Hyderabad, India pp 1-460.

Gupta PK (2010) Modern Toxicology, Immuno and clinicsal toxicology Vol 3. Published by PharmaMed Press (A unit of BSP Books Pvt. Ltd). Hyderabad, India pp 1-340.


                                                                                                                     To be cont'd
Read More

Subscribe

Enter your email address:

Delivered by FeedBurner